- £263.76m
- £479.86m
- £451.20m
- 80
- 68
- 36
- 68
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 385 | 376 | 291 | 394 | 451 |
Cost of Revenue | |||||
Gross Profit | 166 | 164 | 113 | 173 | 198 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 345 | 344 | 294 | 361 | 421 |
Operating Profit | 40.2 | 32 | -3.3 | 33.4 | 30.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 37.9 | 27.6 | -7.7 | 29.6 | 24.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 33.7 | 20.2 | -5.3 | 25.9 | 32.9 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 34.3 | 20.2 | -5.3 | 25.9 | 32.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 34.3 | 20.2 | -5.3 | 25.9 | 32.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.838 | 0.645 | 0.059 | 0.821 | 1.53 |
Dividends per Share |